Investor · San Mateo, CA
Peter C. Mcwilliams
Open Peter in the network graph →Filings
21
SEC Form D
Connections
77
co-filers
Capital
$4.9M
across filings
Active
Jan 2013
to Nov 2016
Most-connected co-filers (77)
Fred A. Middleton · San Mateo, CA8 sharedS. E. Torres · Indianapolis, IN6 sharedPaul M. Quadros · Bloomington, MN5 sharedAllan Wolfe · Salt Lake City, UT5 sharedJohn Bernbach · Newtown, CT4 sharedDavid F. Ferrero · Boston, MA4 sharedAmin Khan · Menlo Park, CA4 sharedJoseph R. Zell · Denver, CO4 sharedDawn Hudson · Boulder, CO4 sharedRene R. Kuijten · Amsterdam, P74 sharedDon Parsons · Boulder, CO4 sharedMichael C. Diem · Malvern, PA4 sharedGilbert N. Miller · Tigard, OR3 sharedShahab Fatheazam · Tigard, OR3 sharedMpg Operations LLC · New York, NY3 sharedAdolph J. Ferro · Tigard, OR3 sharedJohn Berry · Portland, ME3 sharedGail J. Maderis · Emeryville, CA3 sharedBarry R. Edwards · Portland, ME3 sharedHelen S. Kim · New York, NY3 sharedMillennium Smc Management LLC · New York, NY3 sharedJean Hoffman · Portland, ME3 sharedScott A. Segal · Morgantown, WV2 sharedKevin B. Bacon · San Diego, CA2 shared
Recent filings (21)
Actimis Pharmaceuticals IncJun 2017 · 7 co-filers$1.0MActimis Pharmaceuticals IncJun 2017 · 7 co-filers$1.0MGlycomine, Inc.Nov 2016 · 7 co-filers$12.6MGlycomine, Inc.Nov 2016 · 7 co-filers$12.6MSanderling Ventures VII Annex Fund, L.P.Jul 2016 · 7 co-filers$10.0MSanderling Ventures VII Annex Fund, L.P.Jul 2016 · 7 co-filers$10.0MAXIKIN PHARMACEUTICALS INCSep 2015 · 7 co-filers$11.6MExplora Fund, SPC, on behalf of its Explora Brazil Long Only Segregated PortfolioMar 2014 · 5 co-filersExplora Fund, SPC, on behalf of its Equity Long Short Segregated PortfolioMar 2014 · 5 co-filersAXIKIN PHARMACEUTICALS INCMar 2014 · 7 co-filers$6.6MExplora Fund, SPC, on behalf of its Explora Brazil Long Only Segregated PortfolioAug 2013 · 2 co-filersExplora Fund, SPC, on behalf of its Equity Long Short Segregated PortfolioAug 2013 · 2 co-filersSanderling Ventures VII, L.P.Jan 2013 · 8 co-filers$250.0MSanderling Ventures VII, L.P.Jan 2013 · 8 co-filers$250.0MPROTEA BIOSCIENCES INCJan 2011 · 21 co-filersArtielle ImmunoTherapeutics IncSep 2010 · 13 co-filers$100KArtielle ImmunoTherapeutics IncApr 2010 · 13 co-filers$700KTRINITY BIOSYSTEMS INCNov 2009 · 12 co-filers$12.5MTRINITY BIOSYSTEMS INCOct 2009 · 12 co-filers$12.5MGEOPETRO RESOURCES COOct 2009 · 13 co-filers$3.8MTRINITY BIOSYSTEMS INCOct 2009 · 12 co-filers$12.5MArtielle ImmunoTherapeutics IncOct 2009 · 8 co-filers$750KPROTEA BIOSCIENCES INCAug 2009 · 13 co-filers$4.8MTRINITY BIOSYSTEMS INCJun 2009 · 8 co-filers$12.5MGEOPETRO RESOURCES COMay 2009 · 13 co-filers$5.1M
Derived from public SEC Form D (Reg D) filings; entities resolved probabilistically. See Peter in the interactive graph →